Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSS | P25774 | 5/20 | 0.58 |
| ▸ | CTSL | P07711 | 4/20 | 0.58 |
| ▸ | MME | P08473 | 2/20 | 0.57 |
| ▸ | ECE1 | P42892 | 2/20 | 0.57 |
| ▸ | FOLH1 | Q04609 | 2/20 | 0.57 |
| ▸ | CTSB | P07858 | 3/20 | 0.56 |
| ▸ | CTSK | P43235 | 3/20 | 0.56 |
| ▸ | SIRT5 | Q9NXA8 | 4/20 | 0.54 |
| ▸ | HTT | P42858 | 1/20 | 0.52 |
| ▸ | TACR1 | P25103 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14433709 | 1.00 | CTSS (0.58) | CTSSCTSLMMEECE1FOLH1 | |
| SCHEMBL13884485 | 1.00 | CTSS (0.58) | CTSSCTSLMMEECE1FOLH1 | |
| SCHEMBL7543084 | 0.93 | CTSS (0.56) | CTSSCTSLMMEECE1FOLH1 | |
| SCHEMBL36611 | 0.91 | SMN1; SMN2 (0.61) | CTSSCTSLMMEECE1CTSB | |
| SCHEMBL8496964 | 0.91 | SMN1; SMN2 (0.61) | CTSSCTSLMMEECE1CTSB | |
| Hydroxyamine SCHEMBL9197242 | 0.90 | SMN1; SMN2 (0.60) | CTSSCTSLMMEECE1CTSB | |
| SCHEMBL5177047 | 0.90 | CTSS (0.56) | CTSSCTSLFOLH1CTSBCTSK | |
| SCHEMBL22034521 | 0.90 | CTSS (0.58) | CTSSCTSLMMEECE1FOLH1 | |
| SCHEMBL22034518 | 0.90 | CTSS (0.58) | CTSSCTSLMMEECE1FOLH1 | |
| SCHEMBL28707519 | 0.90 | CASP1 (0.60) | CTSSCTSLMMEECE1CTSB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 196 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12538932-B2 | Modified pea protein production method | AJINOMOTO CO., INC. (JP) | 2026-02-03 | — | — | US | disclosed |
| US-20260026530-A1 | PLANT MILK PRODUCTION METHOD | AJINOMOTO CO., INC. (JP) | 2026-01-29 | — | — | US | disclosed |
| EP-4666864-A1 | METHOD FOR PRODUCING MODIFIED PROTEIN-CONTAINING FOOD | AJINOMOTO CO., INC. (JP) | 2025-12-24 | — | — | EP | disclosed |
| US-20250366492-A1 | METHOD FOR PRODUCING MODIFIED PROTEIN-CONTAINING FOOD | AJINOMOTO CO., INC. (JP) | 2025-12-04 | — | — | US | disclosed |
| CN-120400122-A | Enzyme-mediator reactor, preparation method thereof and application thereof in PFOA defluorination | 北京大学 | 2025-08-01 | — | — | CN | disclosed |
| CN-114181878-B | Method for enhancing transcription level of amino acid synthesis gene to increase fermentation level of TG enzyme | 上海交通大学 | 2025-04-08 | — | — | CN | disclosed |
| CN-119709743-A | Streptomyces mobaraensis capable of high-yield heat-resistant glutamine transaminase | 江南大学 | 2025-03-28 | — | — | CN | disclosed |
| EP-4487697-A1 | METHOD FOR MANUFACTURING FLUID GEL | AJINOMOTO CO., INC. (JP) | 2025-01-08 | — | — | EP | disclosed |
| US-20250002892-A1 | PROTEIN-DEAMIDATING ENZYME | AMANO ENZYME INC. (JP) | 2025-01-02 | — | — | US | disclosed |
| US-20240415148-A1 | METHOD FOR MANUFACTURING FLUID GEL | AJINOMOTO CO., INC. (JP) | 2024-12-19 | — | — | US | disclosed |
| EP-0821881-A2 | Milk whey protein-containing powder and processed food obtained by using the same | Ajinomoto Co., Inc. (JP) | 1998-02-04 | — | — | EP | disclosed |
| EP-0815742-A2 | Binding composition comprising transglutaminase and collagen, and process for producing bound food products | Ajinomoto Co., Ltd. (JP) | 1998-01-07 | — | — | EP | disclosed |
| US-5681598-A | ACIDIFICATION; HEAT TREATMENT; MILK CLOTTING ENZYME | AJINOMOTO CO., INC. (JP) | 1997-10-28 | — | — | US | disclosed |
| EP-0760209-A1 | Method of manufacturing baked products | Ajinomoto Co., Inc. (JP) | 1997-03-05 | — | — | EP | disclosed |
| EP-0713651-A1 | Food adhesive | Ajinomoto Co., Inc. (JP) | 1996-05-29 | — | — | EP | disclosed |
| EP-0711504-A1 | Process for producing cheese using transglutaminase | Ajinomoto Co., Inc. (JP) | 1996-05-15 | — | — | EP | disclosed |
| EP-0481504-B1 | Recombinant transglutaminase | AMANO PHARMA CO LTD (JP) | 1996-01-17 | — | — | EP | disclosed |
| US-5420025-A | Recombinant transglutaminase | AMANO PHARMACEUTICAL CO., LTD. (JP) | 1995-05-30 | — | — | US | disclosed |
| WO-1992013530-A1 | TRANSGLUTAMINASE ENZYME INHIBITORS | MEDICIS CORPORATION (US) | 1992-08-20 | — | — | WO | disclosed |
| EP-0481504-A1 | Recombinant transglutaminase | AMANO PHARMACEUTICAL CO., LTD. (JP) | 1992-04-22 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260026530-A1 | PLANT MILK PRODUCTION METHOD | MMP2, LPO, GBA3 | CTSS 403/4885CTSL 633/4885MME 2651/4885 |
| US-12538932-B2 | Modified pea protein production method | TGM2, PGA5, AGL | CTSS 2130/4885CTSL 2167/4885MME 1635/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.